Trial Profile
A Phase I, Randomized, Double-blind, Placebo-Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous SHR0410 in Healthy Male Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs SHR-0410 (Primary)
- Indications Acute pain
- Focus Adverse reactions
- Sponsors Atridia
- 25 Feb 2019 Status changed from recruiting to completed.
- 21 May 2018 Status changed from not yet recruiting to recruiting.
- 16 Apr 2018 New trial record